Ana səhifə

A biotech Professional Proteomics / Imaging Specialist in Biomarker Development with extensive laboratory and data management experience

Yüklə 58 Kb.
ölçüsü58 Kb.
Cameron N. Marlow
1710 Belt Street • Baltimore MD 21230 • (717) 542-4191 •

A Biotech Professional Proteomics / Imaging Specialist in Biomarker Development with extensive laboratory and data management experience.

Summary of Qualifications

  • Ten years combined in the biotechnical field

  • Two years sales and business development experience

  • Five years experience in all aspects of laboratory management

  • Avid enthusiast of developing and learning new technologies

  • Knowledgeable with database design and statistical analysis

  • Committed to seeing assumed projects to completion

  • Outstanding training, leadership, and communication skills

  • Published in several journals with a complete curriculum vitae

Professional Experience

Scientific Applications International Corporation (SAIC-Fredrick)

 Bethesda, MD                                                                                                             2009- Present

Research Associate

  • Develop quality-controlled methodologies for correlative clinical investigations essential to the evaluation of therapeutic efficacy

  • Responsible for facilitating Phase 0 clinical trials

  • Review and edit laboratory Standard Operating Procedures to be followed as a national standard

  • Expertise in quantitative image analysis, programming in Image Pro Plus v6.2

  • ELISA (Enzyme-Linked ImmunoSorbent Assay) development

  • Fluorescence histological staining and cytology

Protea BioSciences inc. Morgantown, WV 2007 - 2008

Sales Specialist

  • Head of sales for the Maryland biotech corridor

  • Established business with all major academic and government research institutions

  • Successfully obtained and fulfilled U.S. government contracts

  • Call on all 300+ Maryland biotech companies

  • Responsible for all product shows in the U.S. and Europe

  • Extensive travel throughout U.S. and Europe at moments notice

  • Self-sufficient in keeping track of personal sales center products and literature

  • Well informed of opportunities through special interest groups, journals, grant searches, etc.

  • Conscientious of customer needs and feedback

  • Seasoned in making product suggestions and communicating with research and development

Johns Hopkins University, Baltimore, MD 2001 – 2007

Laboratory Manager

  • Head technician in biomarker discovery laboratory within Department of Urology

  • Knowledgeable in various statistical software packages, information technology, and operating Systems

  • Responsible for HIPPA compliant clinical and experimental data using a variety of software

  • Johns Hopkins University School of Business database design certification

  • Experienced in histological staining, immunoassay, and ELISA (Enzyme-Linked ImmunoSorbent Assay) development

  • Expertise in quantitative image analysis, programming in Image Pro Plus v6.0, and advanced knowledge of the Olympus (Bacus) Pathology Workstation

  • Responsible for database management and statistical analysis

  • Skilled in proteomics sample preparation: biochemistry/ buffer systems, chromatography, Sephadex columns, Protein-A columns, CAT and ANT ion exchange columns, Ultra-filtration, etc.

  • Electrophoresis experience in 2-Dimentional gels, IEF (Iso Electric Focusing) Tube gels, IPG (Immobilized pH gradient) strips, SDS-PAGE, Western Blot, and Capillary Electrophoresis

  • Blood banking and cell culture experience using aseptic technique

  • Responsible for training of new and visiting staff

  • Contributes to manuscripts and assists with grant preparation including budget justifications

  • Submits grant preparations and budget justifications to Internal Review Board for review and approval

  • Presentation skills: presented Data / Reports to colleagues and seminars

Kelly Scientific, Lancaster, PA 2001 – 2001

Quality Control Technician, Kemps Foods

  • Industrial quality control of several different products

  • Ensured all ingredients and products to be free of bacteria and contamination

  • Produced batch calculation for up to 250,000 gallons of product

  • Tested tank trucks up to 6,000 gallons for contaminants and antibiotics

  • Kept record of all data and documents within accordance to State and Federal guidelines

  • Pennsylvania dairy sampler certification


York College of Pennsylvania, York, PA

Bachelor of Science Biology (2001)

President YCP Ski and Outdoor Club

Lacrosse Team

Additional Information

Computer Skills

  • Operating systems: Windows, Linux, and Mac OS

  • Statistics and Database Management: MS (Microsoft) Excel, MS Access, ACT, STATA, Graphpad Prism, Graphpad Instat, and SPSS

  • Word processing: MS Word, Word Perfect, and

  • Presentation: MS Power Point, Adobe Connect, and

  • Imaging: Mediacybernetics Image Pro Plus, Adobe Illustrator, and Adobe Photoshop


1)      Kortenhorst MS, Isharwal S, van Diest PJ, Chowdhury WH, Marlow C, Carducci MA, Rodriguez R, Veltri RW. “Valproic acid causes dose- and time-dependent changes in nuclear structure in prostate cancer cells in vitro and in vivo.” Mol Cancer Ther. 2009 Apr;8(4):802-8

2)      Isharwal S, Miller MC, Marlow C, Makarov DV, Partin AW, Veltri RW “p300 (histone acetyltransferase) biomarker predicts prostate cancer biochemical recurrence and correlates with changes in epithelia nuclear size and shape”  Prostate. 2008 Jul 1;68(10):1097-104

3)      Veltri RW, Miller MC, Isharwal S, Marlow C, Makarov DV, Partin AW “Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry” Cancer Epidemiol Biomarkers Prev. 2008 Jan;17(1):102-10

4)      Makarov DV, Marlow C, Epstein JI, Miller MC, Landis P, Partin AW, Carter HB, Veltri RW “Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent” Prostate. 2008 Feb 1;68(2):183-9

5)      Veltri RW, Marlow C, Khan MA, Miller MC, Epstein JI, Partin AW “Significant variations in nuclear structure occur between and within Gleason grading patterns 3, 4, and 5 determined by digital image analysis”  Prostate. 2007 Aug 1;67(11):1202-10

6)      Veltri RW, Khan MA, Marlow C, Miller MC, Mikolajczyk SD, Kojima M, Partin AW, Marks LS “Alterations in nuclear structure and expression of proPSA predict differences between native Japanese and Japanese-American prostate cancer” Urology. 2006 Oct;68(4):898-904

7)      Parwani AV, Marlow C, Demarzo AM, Mikolajczyk SD, Rittenhouse HG, Veltri RW, Chan TY “Immunohistochemical staining of precursor forms of prostate-specific antigen (proPSA) in metastatic prostate cancer” Am J Surg Pathol. 2006 Oct;30(10):1231-6

8)      Shiff C, Veltri R, Naples J, Quartey J, Otchere J, Anyan W, Marlow C, Wiredu E, Adjei A, Brakohiapa E, Bosompem K “Shiff C, Veltri R, Naples J, Quartey J, Otchere J, Anyan W, Marlow C, Wiredu E, Adjei A, Brakohiapa E, Bosompem K " Ultrasound verification of bladder damage is associated with known biomarkers of bladder cancer in adults chronically infected with Schistosoma haematobium in Ghana. “Trans R Soc Trop Med Hyg. 2006 Sep;100(9):847-54. Epub 2006 Jan 26.

9)      Veltri RW, Park J, Miller MC, Marks L, Kojima M, Marlow C, Khan MA, Partin AW “Stromal-epithelial measurements of prostate cancer in native Japanese and Japanese-American men” Prostate Cancer Prostatic Dis. 2004;7(3):232-7

10)  Gretzer MB, Chan DW, Marlow C, Rosenzweig JM, Dalrymple S, Mangold LA, Partin AW, Veltri RW “Proteomic analysis of dunning prostate cancer cell lines with variable metastatic potential using SELDI-TOF” Prostate. 2004 Sep 1;60(4):325-31


  1. Cameron Marlow, BS, Danil V Makarov, MD, Zhen Zhang, PhD, Jonathan I Epstein, MD, Patricia Landis, BS, Alan W Partin, MD, PhD, H Ballentine Carter, MD, Robert W Veltri, PhD.. Johns Hopkins Medical Institutions, Baltimore, MD “SURVEILLANCE OF MEN WITH LOW GRADE AND STAGE PROSTATE CANCER ENROLLED IN AN EXPECTANT MANAGEMENT PROGRAM: CHANGES IN CLINICAL, PATHOLOGICAL AND NUCLEAR MORPHOMETRY PATTERNS OBSERVED OVER TIMEModerated Poster Session 50: Prostate Cancer: Markers (II) (3:30 PM - 5:30 PM) American Urological Association Meeting 2007

  2. Danil V Makarov, MD, Cameron Marlow, BS, Jonathan I Epstein, MD, Michael C Miller, Patricia Landis, MS, Alan W Partin, MD, PhD, H Ballentine Carter, MD, Robert W Veltri, PhD.. Johns Hopkins University, Baltimore, MD; None, Quakertown, PA PREDICTING THE NEED FOR TREATMENT AMONG MEN WITH LOW GRADE, LOW STAGE PROSTATE CANCER ENROLLED IN A PROGRAM OF EXPECTANT MANAGEMENT WITH CURATIVE INTENT” Moderated Poster Session 43: Prostate Cancer: Markers (I) (1:00 PM - 3:00 PM) American Urological Association Meeting 2007

  3. Presented scientific data and technologies at several promotional and marketing seminars

  4. Presented a number of peer reviewed presentations at national and international conferences

Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur © 2016
rəhbərliyinə müraciət